• Fiber Density Reconstructs Annulus Fibrosus Collagen

  2026-09-22

  The reference study shows that fiber density in otherwise composition-matched electrospun scaffolds can direct annulus fibrosus cell phenotypes toward collagen type I- or collagen type II-rich matrix programs. Its mechanistic findings connect scaffold microarchitecture with RhoA–ROCK, ERK/AKT, and Piezo1-associated signaling, offering a design principle for rebuilding the native collagen heterogeneity of the annulus fibrosus.

• Deep Learning for iPSC-CM Cardiotoxicity Screening

  2026-09-22

  Grafton et al. developed a high-content screening workflow that combines induced pluripotent stem cell-derived cardiomyocytes with deep-learning image analysis to identify potential drug-induced cardiotoxicity. The approach produced a single-parameter toxicity score across bioactive and chemically diverse libraries, offering an early-stage strategy for prioritizing compounds that require mechanistic and safety follow-up.

• Bafilomycin C1 in High-Content Cell Assays

  2026-09-21

  Bafilomycin C1 is a vacuolar H+-ATPases inhibitor that links lysosomal pH control with rigorous high-content assay design. This guide translates deep-learning phenotyping in iPSC-derived cardiomyocytes into practical decisions for autophagy, toxicity, and mechanistic cell biology workflows.

• Butyrate, Lysosomal Fe2+, and Lung Cancer Stemness

  2026-09-21

  The Heliyon study shows that butyrate attenuates lung cancer stemness through a ferroptosis mechanism involving lysosomal Fe2+ recruitment and reduced SLC7A11 protein stability. Its combined functional, molecular, and in vivo design connects subcellular iron handling with cancer stem cell behavior and chemotherapy sensitivity.

• Diphenyleneiodonium Chloride in Redox Assays

  2026-09-20

  Diphenyleneiodonium chloride enables controlled interrogation of oxidant-generating enzymes while also revealing GPR3-linked cAMP responses. This workflow pairs DPI pharmacology with time-resolved Nrf2 measurements to separate early oxidative signaling from later proteasome-associated pathway loss.

• Bafilomycin C1 for Autophagy Assays

  2026-09-19

  Bafilomycin C1 provides a practical way to connect lysosomal acidification with autophagy, toxicity, and high-content phenotypes. This workflow shows how to use a vacuolar H+-ATPases inhibitor alongside deep-learning image analysis and orthogonal controls without mistaking general cell death for a specific mechanism.

• RIPostC, Ketone Bodies, and Ferroptosis in Stroke

  2026-09-18

  A 2024 ACS Chemical Neuroscience study identifies ketone body production and ferroptosis suppression as a mechanistic link between remote ischemic postconditioning and neuroprotection after ischemic stroke. Its rat and HT22-cell experiments connect improved energy metabolism with GPX4 preservation, ACSL4 reduction, iron control, and mitochondrial protection, providing a framework for testing 3-hydroxybutyrate and related metabolic interventions.

• IL-2, Human Recombinant in Neuronal Granule Studies

  2026-09-18

  Explore how IL-2, human recombinant can serve as a defined signaling perturbation in studies of neuronal granules, FUS phase separation, and SMN function. This article separates established Cell Reports mechanisms from testable cytokine-based experimental applications.

• LG 101506: RXR Signaling to Immune Translation

  2026-09-17

  A translational framework for using LG 101506 to interrogate RXR biology, connect nuclear receptor signaling with immune-checkpoint phenotypes, and test—not assume—relationships between RXR activity and the RBMS1–B4GALT1–PD-L1 axis in triple-negative breast cancer.

• Metabolic Sensitization of Ferroptosis and Cuproptosis

  2026-09-17

  Zhang and colleagues developed a Cu–tannic acid/liposome nanosystem carrying STF-31 to inhibit glycolysis and compensatory NAD+ metabolism, thereby increasing tumor-cell susceptibility to ferroptosis and cuproptosis. The study connects metabolic depletion with copper retention, redox failure, immunogenic cell death, and tumor immune remodeling, offering a mechanistic framework for combination nanomedicine design.

• Rocilinostat (ACY-1215) Experimental Workflow

  2026-09-16

  Rocilinostat (ACY-1215) enables selective HDAC6 target-engagement studies, multiple myeloma viability testing, and carefully controlled proteasome-inhibitor combination experiments. This workflow also shows how α-tubulin acetylation can support hypothesis-generating cilia studies without confusing cancer evidence with developmental biology evidence.

• MG-132: From Proteasome Stress to p53 Strategy

  2026-09-16

  A translational guide to using MG-132 and Z-LLL-al to connect proteasome perturbation with apoptosis, cell-cycle control, oxidative stress, and the emerging XIAP–p53 axis.

• Angiotensin III: A Receptor-Resolved RAAS Tool

  2026-09-15

  Angiotensin III is a powerful cardiovascular research peptide for dissecting receptor-selective RAAS signaling, aldosterone release, and pressor responses. This article adds an assay-centered framework for interpreting emerging spike–receptor binding data without overstating translational evidence.

• CX-4945: CK2 Inhibition Workflow for Lung Cancer

  2026-09-15

  CX-4945 (Silmitasertib) enables a mechanism-led workflow that connects CK2 activity with signaling, ECE-1c stability, apoptosis, cell-cycle behavior, and cisplatin resistance. This practical guide translates lung cancer findings into dosing, controls, readouts, and troubleshooting decisions for reproducible cancer biology experiments.

• Nanoparticle Uptake in Human Corneal Epithelial Cells

  2026-09-14

  Azadi and David systematically examined how PLGA nanoparticle size and surface chemistry influence uptake by human corneal epithelial cells. Their in vitro model linked particle properties to energy-dependent internalization, identifying macropinocytosis and caveolae-mediated endocytosis as dominant pathways while clarifying the limited role of phagocytosis.

8056 records 1/538 page Next 12345 下5页 Last page